Mepilex® Border Heel
Mepilex® Border Heel dressing is the only five-layer foam heel dressing with proprietary Deep Defense Technology® – proven to prevent pressure ulcers when used in conjunction with other standard prevention protocols 1 2 3 4 .
The dressing can also be used for managing moderate- to high- exuding wounds of the heel area. It absorbs and retains exudate 5 6 and it balances moisture properly avoiding the risk of maceration 7 8 .
This recently-launched enhanced design includes new handling tabs and thicker borders, allowing easier application and patient checking 9 . The heel shape has been refined for good coverage of the high-risk heel area and the malleoli.
The enhanced design still includes Safetac® – the original less-pain contact layer with silicone adhesion. So the dressing is comfortable and confirms to the patients anatomy 5 – you can remove it easily without damaging the skin 10 . That means less pain for your patients 11.
- Proven to prevent pressure ulcers – when used with other standard prevention protocols 1 2
- Proprietary Deep Defense Technology protects against the extrinsic forces - pressure, shear and friction; and manages micro-climate, the key factors responsible for pressure ulcers 3 10 5
- Mepilex Border with Safetac technology minimises pain during dressing changes 11 .
- Good fluid handling capacity and retention 7
- Reduces risk of maceration 8
- Van Overschelde P, et al. A randomised controlled trial comparing two wound dressings used after elective hip and knee arthroplasty. Poster presentation at the 5th Congress of WUWHS, Florence, Italy, 25-29 Sep, 2016.
- Zarghooni K, et al. Is the use of modern versus conventional wound dressings warranted after primary knee and hip arthroplasty? Acta Orthop Belg. 2015;81(4):768-775.
- Dobbelaere A, et al. Comparative study of innovative postoperative wound dressings after total knee arthroplasty. Acta orthopaedica Belgica, 2015.
- Bredow J. et al. Evaluation of Absorbent Versus Conventional Wound Dressing. A Randomized Controlled Study in Orthopedic Surgery. Deutsche Arzteblatt Intternational, 2018.
- Mölnlycke Health Care, Data on File internal report 20190215-001
- External test at Nelson Laboratories (viral penetration test), Study Report 1064846-S01
- Statement towards ASTM F 1671 (viral penetration test), PD-404335